Search & Filter
News Type
Topic
Disease
Population
Schaffner Report: Adolescent COVID-19 Vaccination
On May 12, 2021, the Advisory Committee on Immunization Practices recommended that the Pfizer COVID-19 vaccine be used in children age 12-15 years and provided new guidance on co-administration of COVID-19 vaccines with other recommended vaccines, including influenza. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about these important new developments …
Celebrating Mother’s Day in the Time of COVID-19, Again
New vaccines to help prevent COVID-19 have made it possible for many fully vaccinated families to celebrate together in person this Mother’s Day. In 2020, we asked NFID leaders to share their Mother’s Day thoughts, many of which are still relevant today, with some updates …
Closing Vaccination Gaps in Communities of Color
In recognition of National Minority Health Month, NFID and the National Minority Quality Forum (NMQF)—a proud supporter of the NFID Keep Up The Rates campaign—encourage all partners to promote vaccination among communities of color across the US …
Schaffner Report: COVID-19 Vaccine Safety Update
Following a thorough safety review, FDA and CDC have determined that the recommended pause regarding the use of the Johnson & Johnson COVID-19 vaccine in the US should be lifted and use of the vaccine should resume. In this episode of the Schaffner Report, NFID Medical Director William Schaffner, MD, talks with NFID Executive Director and CEO Marla Dalton about the decision and how it may impact confidence in COVID-19 vaccines …
ID News Round-Up: Vaccinology Research
From COVID-19 to new vaccines for cancer, influenza, and malaria, read recent news of interest from the world of infectious diseases, with a focus on vaccinology research …
Experts to Review Latest Vaccinology Research on COVID-19 and Other Infectious Diseases
New Data to be Presented on CMV, Hepatitis B, Herpes Zoster, HPV, Influenza, Meningococcal Disease, and More Bethesda, MD (April 20, 2021)—Global infectious disease researchers…
Schaffner Report: COVID-19 Vaccine Safety and Effectiveness
NFID Medical Director William Schaffner, MD, answers timely questions about the latest data on COVID-19 vaccine safety and effectiveness
NFID Statement on COVID-19 Vaccine Safety
FOR IMMEDIATE RELEASE Bethesda, MD (April 13, 2021)—The following statement can be attributed to William Schaffner, MD, medical director of the National Foundation for Infectious…